Sirtex Medical Limited

Equities

SRX

AU000000SRX1

Biotechnology & Medical Research

End-of-day quote Australian S.E. Other stock markets			5-day change	1st Jan Change
- ^AUD	-.--%		+2.16%	+103.09%

07-15	Sierra Rutile Receives Off-Market Takeover Bid from Leonoil Co.	MT
07-01	Gemcorp to Wholly Acquire Sierra Rutile; Shares Surge 17%	MT

Sierra Rutile 2024 Extraordinary General Meeting Voting Results

June 26, 2024 at 09:10 am

Sierra Rutile Holdings Limited (ASX: SRX) ('Sierra Rutile' or the 'Company') advises the resolution put to the Extraordinary General Meeting of members today was resolved as set out below.

The resolution was decided on a poll called by the Chairman. Following is information on the number of votes cast on the poll in respect to the resolution:

Contact:

Martin Alciaturi

Finance Director, Sierra Rutile

Tel: 08 6251 555

Email: martin.alciaturi@srx.group

Steve Suleski

FTI Consulting

Tel: +61 8 9321 8533

Email: steve.suleski@fticonsulting.com

Stocks mentioned in the article

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
	FTI CONSULTING, INC.	228.2 USD	+2.83%	+5.81%	7.79B
	SIRTEX MEDICAL LIMITED	- AUD	-.--%	+2.16%	0

Latest news about Sirtex Medical Limited

Sierra Rutile Receives Off-Market Takeover Bid from Leonoil Co.	07-14	MT
Gemcorp to Wholly Acquire Sierra Rutile; Shares Surge 17%	07-01	MT
Sierra Rutile Holdings Investigates Fatal Incident at Area 1 Operations	06-18	MT
Takeovers Panel Rejects PRM Services' Application Regarding Sierra Rutile Takeover	06-17	MT
Strike Action Resolved at Sierra Rutile Operations	05-30	MT
Sierra Rutile Completes Restart of Area 1 Operations in Sierra Leone	05-29	MT
Sierra Rutile Holdings Operations Interrupted by Strikes in Sierra Leone	05-28	MT
Sierra Rutile Intends to Restart Area 1 Operations in Sierra Leone; Shares Up 10%	05-08	MT
PRM Extends Takeover Offer for Sierra Rutile	04-29	MT
Sierra Rutile Tells Shareholders to Reject PRM Services' Takover Bid	04-14	MT
Euroz Hartleys Adjusts Sierra Rutile Holdings’ Price Target to AU$0.15 From AU$0.12, Keeps at Speculative Buy	04-12	MT
Sierra Rutile Holdings Study Shows 11% Reduced Capex to $301 Million, $408 Million NPV, 27.8% IRR	04-11	MT
Sierra Rutile Tells Shareholders to Reject RPM Services' Takeover Bid	04-07	MT
Sierra Rutile Reports Lower Capex for Sierra Leone Rutile Project	03-27	MT
Australian Shares Inch Down as Metal Prices Retreat Amid Stronger US Dollar	03-20	MT
Sierra Rutile Jumps 31% Following Takeover Offer from PRM Services	03-19	MT
Sierra Rutile Holdings Receives AU$0.095 Per Share Takeover Bid From PRM Services	03-19	MT
Sierra Rutile Falls 3% Amid 2023 Loss Swing, Workforce Redundancy Program	02-27	MT
Sierra Rutile Falls to 2023 Loss per Share of $0.0473 as Revenue Falls 31%	02-27	MT
Sierra Rutile Posts FY23 Revenue Down 31% to $176.3 Million; Loss of $0.0473	02-27	MT
Sierra Rutile Gets Environmental Approval for Sierra Leone Rutile Project	01-29	MT
Sierra Rutile Holdings Announces Suspension of Area 1 Operations in Sierra Leoe	01-29	MT
Sierra Rutile Expects No Bulk Sales in Q1 2024	12-15	MT
Sierra Rutile Confirms Power Restoration at Sierra Leone Operation	23-08-09	MT
Sierra Rutile Revises Production Guidance Following Power Disruptions	23-06-14	MT

Chart Sirtex Medical Limited

Duration

Period

More charts

Company Profile

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
SIRTEX MEDICAL LIMITED	+103.09%	0
MODERNA, INC.	+26.36%	46.56B
LONZA GROUP AG	+45.38%	41.67B
IQVIA HOLDINGS INC.	+0.88%	41.16B
ALNYLAM PHARMACEUTICALS, INC.	+31.33%	32.4B
ICON PUBLIC LIMITED COMPANY	+22.23%	28.18B
CELLTRION, INC.	-6.35%	28.1B
UNITED THERAPEUTICS CORPORATION	+49.17%	14.52B
MEDPACE HOLDINGS, INC.	+48.86%	13.74B
BIO-TECHNE CORPORATION	+3.68%	12.17B

Other Biotechnology & Medical Research